WM TECHNOLOGY INC (MAPS)

US92971A1097 - Common Stock

1.19  +0.02 (+1.71%)

Fundamental Rating

4

MAPS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 279 industry peers in the Software industry. MAPS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. MAPS has a bad growth rate and is valued cheaply.



3

1. Profitability

1.1 Basic Checks

In the past year MAPS has reported negative net income.
In the past year MAPS had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: MAPS reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: MAPS reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -3.98%, MAPS is in line with its industry, outperforming 51.25% of the companies in the same industry.
MAPS's Return On Equity of -27.37% is on the low side compared to the rest of the industry. MAPS is outperformed by 60.93% of its industry peers.
MAPS's Return On Invested Capital of 9.99% is amongst the best of the industry. MAPS outperforms 87.46% of its industry peers.
Industry RankSector Rank
ROA -3.98%
ROE -27.37%
ROIC 9.99%
ROA(3y)-15.89%
ROA(5y)-13.47%
ROE(3y)-277.04%
ROE(5y)-171.91%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

MAPS has a Operating Margin of 9.70%. This is in the better half of the industry: MAPS outperforms 77.78% of its industry peers.
MAPS's Gross Margin of 94.24% is amongst the best of the industry. MAPS outperforms 98.92% of its industry peers.
Industry RankSector Rank
OM 9.7%
PM (TTM) N/A
GM 94.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

MAPS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for MAPS has been increased compared to 1 year ago.
MAPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of 1.80, we must say that MAPS is in the distress zone and has some risk of bankruptcy.
MAPS has a Altman-Z score (1.80) which is in line with its industry peers.
There is no outstanding debt for MAPS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 1.8
ROIC/WACC0.84
WACC11.9%

2.3 Liquidity

A Current Ratio of 1.77 indicates that MAPS should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.77, MAPS is in line with its industry, outperforming 53.76% of the companies in the same industry.
A Quick Ratio of 1.77 indicates that MAPS should not have too much problems paying its short term obligations.
MAPS's Quick ratio of 1.77 is in line compared to the rest of the industry. MAPS outperforms 54.12% of its industry peers.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.77

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 97.56% over the past year.
The Revenue for MAPS has decreased by -12.76% in the past year. This is quite bad
EPS 1Y (TTM)97.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%250%
Revenue 1Y (TTM)-12.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-2.46%

3.2 Future

The Earnings Per Share is expected to grow by 63.62% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 5.94% on average over the next years.
EPS Next Y189.25%
EPS Next 2Y86.75%
EPS Next 3Y63.62%
EPS Next 5YN/A
Revenue Next Year-8.25%
Revenue Next 2Y0.05%
Revenue Next 3Y5.31%
Revenue Next 5Y5.94%

3.3 Evolution

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MAPS. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 6.67, which indicates a rather cheap valuation of MAPS.
97.13% of the companies in the same industry are more expensive than MAPS, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 23.82. MAPS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 6.67

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MAPS is valued cheaper than 97.85% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MAPS is valued cheaper than 98.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.08
EV/EBITDA 4.64

4.3 Compensation for Growth

MAPS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MAPS's earnings are expected to grow with 63.62% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y86.75%
EPS Next 3Y63.62%

0

5. Dividend

5.1 Amount

No dividends for MAPS!.
Industry RankSector Rank
Dividend Yield N/A

WM TECHNOLOGY INC

NASDAQ:MAPS (11/22/2024, 9:45:59 AM)

1.19

+0.02 (+1.71%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap181.90M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.67
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.98%
ROE -27.37%
ROCE
ROIC
ROICexc
ROICexgc
OM 9.7%
PM (TTM) N/A
GM 94.24%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.77
Quick Ratio 1.77
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)97.56%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y189.25%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-12.76%
Revenue growth 3YN/A
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y